A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

April 27, 2016

Primary Completion Date

September 15, 2017

Study Completion Date

December 14, 2017

Conditions
Diabetic Macular Edema
Interventions
DRUG

Faricimab

Faricimab will be administered by IVT injection in the study eye.

DRUG

Ranibizumab

Ranibizumab will be administered by IVT injection in the study eye.

Trial Locations (60)

11563

Opthalmic Consultants of LI, Lynbrook

12206

Capital Region Retina, Albany

14127

Retina Consultants of Western New York, Orchard Park

21287

Wilmer Eye Institute, Baltimore

22903

Univ of Virginia Ophthalmology, Charlottesville

26506

West Virginia University Eye Institute, Morgantown

28210

Char Eye Ear &Throat Assoc, Charlotte

28803

Western Carolina Retinal Associate PA, Asheville

29456

Charleston Neuroscience Inst, Ladson

29501

Palmetto Retina Center, Florence

30060

Georgia Retina PC, Marietta

30909

Southeast Retina Center, Augusta

32308

Southern Vitreoretinal Assoc, Tallahassee

32503

Retina Specialty Institute, Pensacola

32901

Florida Eye Associates, Melbourne

33064

Rand Eye, Deerfield Beach

33711

Retina Vitreous Assoc of FL, St. Petersburg

33912

National Ophthalmic Research Institute, Fort Myers

37203

Tennessee Retina PC., Nashville

38138

Charles Retina Institute, Germantown

40509

Retina Associates of Kentucky, Lexington

42001

Paducah Retinal Center, Paducah

43212

OSU Eye Physicians & Surgeons, Columbus

44195

Cleveland Clinic Foundation; Cole Eye Institute, Cleveland

46290

Midwest Eye Institute, Indianapolis

49546

Vitreo-Retinal Associates, Grand Rapids

50266

Wolfe Eye Clinic, West Des Moines

55435

Vitreoretinal Surgery, Edina

60304

Illinois Retina Associates SC, Oak Park

60452

University Retina and Macula Associates, PC, Oak Forest

60612

Univ of Illinois at Chicago, Chicago

75115

Retina Specialists, DeSoto

77030

Retina Consultants of Houston, Houston

77384

Retina Consultants of Houston, The Woodlands

78240

Med Center Ophthalmology Assoc, San Antonio

78705

Austin Retina Associates, Austin

Retina Consultants of Austin, Austin

79606

W Texas Retina Consultants PA, Abilene

80909

Retina Consultants of Southern, Colorado Springs

84107

Retina Associates of Utah, Salt Lake City

85014

Retinal Research Institute, LLC, Phoenix

85020

Associated Retina Consultants, Phoenix

85021

Arizona Retina and Vitreous Consultants, Phoenix

85750

Retina Associates Southwest PC, Tucson

87102

Eye Associates of New Mexico, Albuquerque

87131

University of New Mexico, Albuquerque

89502

Sierra Eye Associates, Reno

90301

United Med Res Inst, Inglewood

92056

Ophthalmic Clinical Trials San Diego, Oceanside

92064

Retina Consultants, San Diego, Poway

92211

Southern CA Desert Retina Cons, Palm Desert

92835

Retina Consultants of Orange County, Fullerton

93103

California Retina Consultants, Santa Barbara

94040

Northern California Retina Vitreous Associates, Mountain View

94598

Bay Area Retina Associates, Walnut Creek

95825

Retinal Consultants Med Group, Sacramento

97221

Retina Northwest, Portland

97401

Oregon Retina, LLP, Eugene

99204

Spokane Eye Clinical Research, Spokane

07003

Retina Center of New Jersey, Bloomfield

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02699450 - A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema | Biotech Hunter | Biotech Hunter